Compile Data Set for Download or QSAR
maximum 50k data
Found 115 with Last Name = 'roux' and Initial = 'p'
TargetSomatostatin receptor type 5(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM50019568(Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-...)
Affinity DataKi:  2.60nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM50019568(Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-...)
Affinity DataKi:  3.80nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM50019568(Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-...)
Affinity DataKi:  4.5nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM82253(BIM 23052 | CAS_133073-82-2)
Affinity DataKi:  4.60nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM50019568(Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-...)
Affinity DataKi:  6.5nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 4(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM50019568(Ala-Gly-c(Cys-Lys-Asn-Phe-Phe-Trp-Lys-Thr-Phe-Thr-...)
Affinity DataKi:  6.60nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM82253(BIM 23052 | CAS_133073-82-2)
Affinity DataKi:  8.20nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 4(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM82253(BIM 23052 | CAS_133073-82-2)
Affinity DataKi:  8.40nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM84629(BIM 23056)
Affinity DataKi:  32.5nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM85080(CH-275 | CH275 | L-Cys(1)-L-Lys-L-Phe-L-Phe-D-Trp-...)
Affinity DataKi:  45.7nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 4(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM84629(BIM 23056)
Affinity DataKi:  83.8nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM82253(BIM 23052 | CAS_133073-82-2)
Affinity DataKi:  163nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 5(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM85080(CH-275 | CH275 | L-Cys(1)-L-Lys-L-Phe-L-Phe-D-Trp-...)
Affinity DataKi:  279nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 1(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM84629(BIM 23056)
Affinity DataKi:  301nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM84629(BIM 23056)
Affinity DataKi:  380nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 4(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM85080(CH-275 | CH275 | L-Cys(1)-L-Lys-L-Phe-L-Phe-D-Trp-...)
Affinity DataKi:  465nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 3(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM85080(CH-275 | CH275 | L-Cys(1)-L-Lys-L-Phe-L-Phe-D-Trp-...)
Affinity DataKi:  577nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM84629(BIM 23056)
Affinity DataKi:  835nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSomatostatin receptor type 2(RAT)
Dynamique Des Systemes Neuroendocriniens

Curated by PDSP Ki Database
LigandPNGBDBM85080(CH-275 | CH275 | L-Cys(1)-L-Lys-L-Phe-L-Phe-D-Trp-...)
Affinity DataKi:  1.00E+3nMMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176622(US9115121, 13)
Affinity DataIC50:  0.400nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176622(US9115121, 13)
Affinity DataIC50:  0.580nMAssay Description:Binding affinity to human CB2 receptorMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176645(US9115121, 37)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176668(US9115121, 65)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176606(US9115121, 58)
Affinity DataIC50:  1nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176604(US9115121, 46)
Affinity DataIC50:  1.20nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM50494951(CHEMBL3099054)
Affinity DataIC50:  1.40nMAssay Description:Binding affinity to human CB2 receptor expressed in CHO cellsMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails ArticlePubMed
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176620(US9115121, 11)
Affinity DataIC50:  2.70nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176660(US9115121, 53)
Affinity DataIC50:  3nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176610(US9115121, 69)
Affinity DataIC50:  3.90nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176654(US9115121, 47)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176656(US9115121, 49)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176666(US9115121, 62)
Affinity DataIC50:  4nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176638(US9115121, 30)
Affinity DataIC50:  5nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176602(US9115121, 18)
Affinity DataIC50:  7nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176623(US9115121, 14)
Affinity DataIC50:  8nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176605(US9115121, 56)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176616(US9115121, 7)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176671(US9115121, 70)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176661(US9115121, 54)
Affinity DataIC50:  9nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176608(US9115121, 63)
Affinity DataIC50:  10nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176619(US9115121, 10)
Affinity DataIC50:  10nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176612(US9115121, 3)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176670(US9115121, 68)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176641(US9115121, 33)
Affinity DataIC50:  11nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176601(US9115121, 12)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176657(US9115121, 50)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176603(US9115121, 20)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176615(US9115121, 6)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176655(US9115121, 48)
Affinity DataIC50:  12nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetCannabinoid receptor 2(Homo sapiens (Human))
Sanofi

US Patent
LigandPNGBDBM176637(US9115121, 29)
Affinity DataIC50:  14nMAssay Description:Affinity binding tests were performed according to the experimental conditions described by M. Rinaldi-Carmona in J. Pharmacol. Exp. Therap. 1998, 28...More data for this Ligand-Target Pair
In DepthDetails US Patent
Displayed 1 to 50 (of 115 total ) | Next | Last >>
Jump to: